Purchase of Own Securities

GlaxoSmithKline PLC 10 September 2004 GlaxoSmithKline plc (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 17 May 2004 it purchased 430,000 of its Ordinary shares of 25 pence each ("shares") on 10 September 2004 at a price of 1153.3023 pence per share. The Company intends to hold these shares in Treasury. Following the purchase of these shares, the Company holds 42,873,000 of its shares in Treasury and has 5,891,612,674 shares in issue (excluding Treasury shares). This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction. This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings